,xrefs_inchikey,associated_pathways_kegg_map_id,associated_pathways_name,associated_pathways_type,associated_pathways_smpdb_id
0,WHBMMWSBFZVSSR-GSVOUGTGSA-N,,fatty acid biosynthesis,biolink:Pathway,SMP00456
0,WHBMMWSBFZVSSR-GSVOUGTGSA-N,map00072,ketone body metabolism,biolink:Pathway,SMP00071
0,WHBMMWSBFZVSSR-GSVOUGTGSA-N,,succinyl coa: 3-ketoacid coa transferase deficiency,biolink:Pathway,SMP00569
1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,,alkaptonuria,biolink:Pathway,SMP00169
1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
2,FERIUCNNQQJTOY-UHFFFAOYSA-N,map00650,butyrate metabolism,biolink:Pathway,SMP00073
2,FERIUCNNQQJTOY-UHFFFAOYSA-N,,fatty acid biosynthesis,biolink:Pathway,SMP00456
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,map00520,amino sugar metabolism,biolink:Pathway,SMP00045
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,map00250,aspartate metabolism,biolink:Pathway,SMP00067
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,canavan disease,biolink:Pathway,SMP00175
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,ethanol degradation,biolink:Pathway,SMP00449
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,fatty acid biosynthesis,biolink:Pathway,SMP00456
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,"g(m2)-gangliosidosis: variant b, tay-sachs disease",biolink:Pathway,SMP00534
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,heroin action pathway,biolink:Pathway,SMP00407
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,heroin metabolism pathway,biolink:Pathway,SMP00623
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,hypoacetylaspartia,biolink:Pathway,SMP00192
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,leigh syndrome,biolink:Pathway,SMP00196
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,"primary hyperoxaluria ii, ph2",biolink:Pathway,SMP00558
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,pyruvate decarboxylase e1 component deficiency (pdhe1 deficiency),biolink:Pathway,SMP00334
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,pyruvate dehydrogenase complex deficiency,biolink:Pathway,SMP00212
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,pyruvate kinase deficiency,biolink:Pathway,SMP00559
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,map00620,pyruvate metabolism,biolink:Pathway,
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,salla disease/infantile sialic acid storage disease,biolink:Pathway,SMP00240
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,sialuria or french type sialuria,biolink:Pathway,SMP00216
3,QTBSBXVTEAMEQO-UHFFFAOYSA-N,,tay-sachs disease,biolink:Pathway,SMP00390
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,alkaptonuria,biolink:Pathway,SMP00169
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,aromatic l-aminoacid decarboxylase deficiency,biolink:Pathway,SMP00170
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,carnitine synthesis,biolink:Pathway,SMP00465
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,oxidation of branched chain fatty acids,biolink:Pathway,SMP00030
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,phytanic acid peroxisomal oxidation,biolink:Pathway,SMP00450
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,refsum disease,biolink:Pathway,SMP00451
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,the oncogenic action of fumarate,biolink:Pathway,SMP02295
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,the oncogenic action of succinate,biolink:Pathway,SMP02292
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,tyrosine hydroxylase deficiency,biolink:Pathway,SMP00497
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,map00350,tyrosine metabolism,biolink:Pathway,
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,map00350,tyrosine metabolism,biolink:Pathway,
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
4,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
5,DLRVVLDZNNYCBX-CQHUIXDMSA-N,map00052,galactose metabolism,biolink:Pathway,SMP00043
5,DLRVVLDZNNYCBX-CQHUIXDMSA-N,,galactosemia,biolink:Pathway,SMP00182
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,alkaptonuria,biolink:Pathway,SMP00169
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,aromatic l-aminoacid decarboxylase deficiency,biolink:Pathway,SMP00170
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,epinephrine action pathway,biolink:Pathway,SMP00661
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,hawkinsinuria,biolink:Pathway,SMP00190
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,tyrosine hydroxylase deficiency,biolink:Pathway,SMP00497
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,map00350,tyrosine metabolism,biolink:Pathway,
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,map00350,tyrosine metabolism,biolink:Pathway,
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
6,UCTWMZQNUQWSLP-VIFPVBQESA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,3-methylthiofentanyl action pathway,biolink:Pathway,SMP00679
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,alfentanil action pathway,biolink:Pathway,SMP00413
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,alkaptonuria,biolink:Pathway,SMP00169
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,alvimopan action pathway,biolink:Pathway,SMP00685
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,anileridine action pathway,biolink:Pathway,SMP00674
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,aromatic l-aminoacid decarboxylase deficiency,biolink:Pathway,SMP00170
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,benzocaine action pathway,biolink:Pathway,SMP00392
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,bupivacaine action pathway,biolink:Pathway,SMP00393
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,buprenorphine action pathway,biolink:Pathway,SMP00684
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,carfentanil action pathway,biolink:Pathway,SMP00414
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,chloroprocaine action pathway,biolink:Pathway,SMP00394
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,citalopram action pathway,biolink:Pathway,SMP00424
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,cocaine action pathway,biolink:Pathway,SMP00395
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,codeine action pathway,biolink:Pathway,SMP00405
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,desipramine action pathway,biolink:Pathway,SMP00423
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,dezocine action pathway,biolink:Pathway,SMP00676
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,dibucaine action pathway,biolink:Pathway,SMP00396
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,dihydromorphine action pathway,biolink:Pathway,SMP00689
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,dimethylthiambutene action pathway,biolink:Pathway,SMP00680
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,diphenoxylate action pathway,biolink:Pathway,SMP00675
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,dopamine activation of neurological reward system,biolink:Pathway,SMP00308
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,escitalopram action pathway,biolink:Pathway,SMP00425
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,ethylmorphine action pathway,biolink:Pathway,SMP00681
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,fentanyl action pathway,biolink:Pathway,SMP00415
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,fluoxetine action pathway,biolink:Pathway,SMP00426
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,heroin action pathway,biolink:Pathway,SMP00407
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,hydrocodone action pathway,biolink:Pathway,SMP00411
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,hydromorphone action pathway,biolink:Pathway,SMP00410
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,imipramine action pathway,biolink:Pathway,SMP00422
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,ketobemidone  action pathway,biolink:Pathway,SMP00690
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,levallorphan action pathway,biolink:Pathway,SMP00683
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,levobupivacaine action pathway,biolink:Pathway,SMP00397
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,levomethadyl acetate action action pathway,biolink:Pathway,SMP00677
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,levorphanol action pathway,biolink:Pathway,SMP00673
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,lidocaine (local anaesthetic) action pathway,biolink:Pathway,SMP00398
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,mepivacaine action pathway,biolink:Pathway,SMP00399
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,methadone action pathway,biolink:Pathway,SMP00408
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,methadyl acetate action pathway,biolink:Pathway,SMP00678
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,morphine action pathway,biolink:Pathway,SMP00406
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,nalbuphine action pathway,biolink:Pathway,SMP00691
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,naloxone action pathway,biolink:Pathway,SMP00688
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,naltrexone action pathway,biolink:Pathway,SMP00687
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,nicotine action pathway,biolink:Pathway,SMP00431
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,oxybuprocaine action pathway,biolink:Pathway,SMP00400
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,oxycodone action pathway,biolink:Pathway,SMP00409
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,oxymorphone action pathway,biolink:Pathway,SMP00412
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,pentazocine action pathway,biolink:Pathway,SMP00686
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,prilocaine action pathway,biolink:Pathway,SMP00401
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,procaine action pathway,biolink:Pathway,SMP00402
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,proparacaine action pathway,biolink:Pathway,SMP00403
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,propoxyphene action pathway,biolink:Pathway,SMP00672
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,remifentanil action pathway,biolink:Pathway,SMP00416
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,ropivacaine action pathway,biolink:Pathway,SMP00404
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,sufentanil action pathway,biolink:Pathway,SMP00417
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,tramadol action action pathway,biolink:Pathway,SMP00671
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,tyrosine hydroxylase deficiency,biolink:Pathway,SMP00497
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
7,VYFYYTLLBUKUHU-UHFFFAOYSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
8,ROSDSFDQCJNGOL-UHFFFAOYSA-N,,citalopram action pathway,biolink:Pathway,SMP00424
8,ROSDSFDQCJNGOL-UHFFFAOYSA-N,,citalopram metabolism pathway,biolink:Pathway,SMP00627
9,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
9,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,,ethanol degradation,biolink:Pathway,SMP00449
10,BTCSSZJGUNDROE-UHFFFAOYSA-N,,2-hydroxyglutric aciduria (d and l form),biolink:Pathway,SMP00136
10,BTCSSZJGUNDROE-UHFFFAOYSA-N,,4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00243
10,BTCSSZJGUNDROE-UHFFFAOYSA-N,map00250,glutamate metabolism,biolink:Pathway,SMP00072
10,BTCSSZJGUNDROE-UHFFFAOYSA-N,,homocarnosinosis,biolink:Pathway,SMP00385
10,BTCSSZJGUNDROE-UHFFFAOYSA-N,,hyperinsulinism-hyperammonemia syndrome,biolink:Pathway,SMP00339
10,BTCSSZJGUNDROE-UHFFFAOYSA-N,,succinic semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00567
11,AEMRFAOFKBGASW-UHFFFAOYSA-N,,,,
12,QRMZSPFSDQBLIX-UHFFFAOYSA-N,,alkaptonuria,biolink:Pathway,SMP00169
12,QRMZSPFSDQBLIX-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
12,QRMZSPFSDQBLIX-UHFFFAOYSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
12,QRMZSPFSDQBLIX-UHFFFAOYSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
12,QRMZSPFSDQBLIX-UHFFFAOYSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
12,QRMZSPFSDQBLIX-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
12,QRMZSPFSDQBLIX-UHFFFAOYSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
12,QRMZSPFSDQBLIX-UHFFFAOYSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
13,OVBPIULPVIDEAO-LBPRGKRZSA-N,,"folate malabsorption, hereditary",biolink:Pathway,SMP00724
13,OVBPIULPVIDEAO-LBPRGKRZSA-N,,methotrexate action pathway,biolink:Pathway,SMP00432
13,OVBPIULPVIDEAO-LBPRGKRZSA-N,,methylenetetrahydrofolate reductase deficiency (mthfrd),biolink:Pathway,SMP00543
13,OVBPIULPVIDEAO-LBPRGKRZSA-N,map00670,one carbon pool by folate,biolink:Pathway,
13,OVBPIULPVIDEAO-LBPRGKRZSA-N,map00790,pterine biosynthesis,biolink:Pathway,SMP00005
14,RFDAIACWWDREDC-FRVQLJSFSA-N,,27-hydroxylase deficiency,biolink:Pathway,SMP00720
14,RFDAIACWWDREDC-FRVQLJSFSA-N,,cerebrotendinous xanthomatosis (ctx),biolink:Pathway,SMP00315
14,RFDAIACWWDREDC-FRVQLJSFSA-N,,congenital bile acid synthesis defect type ii,biolink:Pathway,SMP00314
14,RFDAIACWWDREDC-FRVQLJSFSA-N,,congenital bile acid synthesis defect type iii,biolink:Pathway,SMP00318
14,RFDAIACWWDREDC-FRVQLJSFSA-N,,familial hypercholanemia (fhca),biolink:Pathway,SMP00317
14,RFDAIACWWDREDC-FRVQLJSFSA-N,map00120,primary bile acid biosynthesis,biolink:Pathway,
14,RFDAIACWWDREDC-FRVQLJSFSA-N,,zellweger syndrome,biolink:Pathway,SMP00316
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,17-beta hydroxysteroid dehydrogenase iii deficiency,biolink:Pathway,SMP00356
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,alendronate action pathway,biolink:Pathway,SMP00095
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,map00150,androgen and estrogen metabolism,biolink:Pathway,SMP00068
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,androstenedione metabolism,biolink:Pathway,SMP30406
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,aromatase deficiency,biolink:Pathway,SMP00565
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,atorvastatin action pathway,biolink:Pathway,SMP00131
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,cerivastatin action pathway,biolink:Pathway,SMP00111
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,child syndrome,biolink:Pathway,SMP00387
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,cholesteryl ester storage disease,biolink:Pathway,SMP00508
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,"chondrodysplasia punctata ii, x linked dominant (cdpx2)",biolink:Pathway,SMP00388
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,desmosterolosis,biolink:Pathway,SMP00386
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,dopa-responsive dystonia,biolink:Pathway,SMP00486
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,fluvastatin action pathway,biolink:Pathway,SMP00119
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,"folate malabsorption, hereditary",biolink:Pathway,SMP00724
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,hyper-igd syndrome,biolink:Pathway,SMP00509
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,hypercholesterolemia,biolink:Pathway,SMP00209
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,biolink:Pathway,SMP00487
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),biolink:Pathway,SMP00488
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,hyperphenylalaninemia due to dhpr-deficiency,biolink:Pathway,SMP00489
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,ibandronate action pathway,biolink:Pathway,SMP00079
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,lovastatin action pathway,biolink:Pathway,SMP00099
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,lysosomal acid lipase deficiency (wolman disease),biolink:Pathway,SMP00319
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,methotrexate action pathway,biolink:Pathway,SMP00432
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,methylenetetrahydrofolate reductase deficiency (mthfrd),biolink:Pathway,SMP00543
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,mevalonic aciduria,biolink:Pathway,SMP00510
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,map00670,one carbon pool by folate,biolink:Pathway,
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,pamidronate action pathway,biolink:Pathway,SMP00117
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,pravastatin action pathway,biolink:Pathway,SMP00089
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,map00790,pterine biosynthesis,biolink:Pathway,SMP00005
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,risedronate action pathway,biolink:Pathway,SMP00112
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,rosuvastatin action pathway,biolink:Pathway,SMP00092
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,segawa syndrome,biolink:Pathway,SMP00490
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,sepiapterin reductase deficiency,biolink:Pathway,SMP00491
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,simvastatin action pathway,biolink:Pathway,SMP00082
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,smith-lemli-opitz syndrome (slos),biolink:Pathway,SMP00389
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,map00100,steroid biosynthesis,biolink:Pathway,SMP00023
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,map00380,tryptophan metabolism,biolink:Pathway,
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,wolman disease,biolink:Pathway,SMP00511
15,BDAGIHXWWSANSR-UHFFFAOYSA-N,,zoledronate action pathway,biolink:Pathway,SMP00107
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,"fructose-1,6-diphosphatase deficiency",biolink:Pathway,SMP00562
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,glutaminolysis and cancer,biolink:Pathway,SMP02298
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,glycogen storage disease type 1a (gsd1a) or von gierke disease,biolink:Pathway,SMP00374
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,"glycogenosis, type ia. von gierke disease",biolink:Pathway,SMP00581
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,"glycogenosis, type ib",biolink:Pathway,SMP00573
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,"glycogenosis, type ic",biolink:Pathway,SMP00574
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,map00010,glycolysis / gluconeogenesis,biolink:Pathway,
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,leigh syndrome,biolink:Pathway,SMP00196
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,phosphoenolpyruvate carboxykinase deficiency 1 (pepck1),biolink:Pathway,SMP00560
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,"primary hyperoxaluria ii, ph2",biolink:Pathway,SMP00558
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,pyruvate decarboxylase e1 component deficiency (pdhe1 deficiency),biolink:Pathway,SMP00334
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,pyruvate dehydrogenase complex deficiency,biolink:Pathway,SMP00212
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,pyruvate kinase deficiency,biolink:Pathway,SMP00559
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,map00620,pyruvate metabolism,biolink:Pathway,
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,triosephosphate isomerase,biolink:Pathway,SMP00563
16,JVTAAEKCZFNVCJ-REOHCLBHSA-N,,warburg effect,biolink:Pathway,SMP00654
17,SEOVTRFCIGRIMH-UHFFFAOYSA-N,map00380,tryptophan metabolism,biolink:Pathway,
18,BTNMPGBKDVTSJY-UHFFFAOYSA-N,map00360,phenylalanine and tyrosine metabolism,biolink:Pathway,SMP00008
18,BTNMPGBKDVTSJY-UHFFFAOYSA-N,,phenylketonuria,biolink:Pathway,SMP00206
18,BTNMPGBKDVTSJY-UHFFFAOYSA-N,,tyrosinemia type 2 (or richner-hanhart syndrome),biolink:Pathway,SMP00369
18,BTNMPGBKDVTSJY-UHFFFAOYSA-N,,tyrosinemia type 3 (tyro3),biolink:Pathway,SMP00370
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,2-aminoadipic 2-oxoadipic aciduria,biolink:Pathway,SMP00719
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,2-hydroxyglutric aciduria (d and l form),biolink:Pathway,SMP00136
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,2-ketoglutarate dehydrogenase complex deficiency,biolink:Pathway,SMP00549
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,2-methyl-3-hydroxybutryl coa dehydrogenase deficiency,biolink:Pathway,SMP00137
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,3-hydroxy-3-methylglutaryl-coa lyase deficiency,biolink:Pathway,SMP00138
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,3-hydroxyisobutyric acid dehydrogenase deficiency,biolink:Pathway,SMP00521
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,3-hydroxyisobutyric aciduria,biolink:Pathway,SMP00522
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,3-methylcrotonyl coa carboxylase deficiency type i,biolink:Pathway,SMP00237
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,3-methylglutaconic aciduria type i,biolink:Pathway,SMP00139
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,3-methylglutaconic aciduria type iii,biolink:Pathway,SMP00140
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,3-methylglutaconic aciduria type iv,biolink:Pathway,SMP00141
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,3-phosphoglycerate dehydrogenase deficiency,biolink:Pathway,SMP00721
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00243
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00250,"alanine, aspartate and glutamate metabolism",biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,alkaptonuria,biolink:Pathway,SMP00169
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00330,arginine and proline metabolism,biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,arginine: glycine amidinotransferase deficiency (agat deficiency),biolink:Pathway,SMP00362
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,argininemia,biolink:Pathway,SMP00357
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,argininosuccinic aciduria,biolink:Pathway,SMP00003
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00250,aspartate metabolism,biolink:Pathway,SMP00067
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00410,beta-alanine metabolism,biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,beta-ketothiolase deficiency,biolink:Pathway,SMP00173
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,beta-mercaptolactate-cysteine disulfiduria,biolink:Pathway,SMP00499
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,canavan disease,biolink:Pathway,SMP00175
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,carbamoyl phosphate synthetase deficiency,biolink:Pathway,SMP00002
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,carnitine synthesis,biolink:Pathway,SMP00465
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"carnosinuria, carnosinemia",biolink:Pathway,SMP00493
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00020,citric acid cycle,biolink:Pathway,SMP00057
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,citrullinemia type i,biolink:Pathway,SMP00001
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,congenital lactic acidosis,biolink:Pathway,SMP00546
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"creatine deficiency, guanidinoacetate methyltransferase deficiency",biolink:Pathway,SMP00504
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00270,cysteine metabolism,biolink:Pathway,SMP00013
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"cystinosis, ocular nonnephropathic",biolink:Pathway,SMP00722
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,dihydropyrimidine dehydrogenase deficiency (dhpd),biolink:Pathway,SMP00179
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,dimethylglycine dehydrogenase deficiency,biolink:Pathway,SMP00242
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,dimethylglycine dehydrogenase deficiency,biolink:Pathway,SMP00484
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"fructose-1,6-diphosphatase deficiency",biolink:Pathway,SMP00562
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,fumarase deficiency,biolink:Pathway,SMP00547
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,gaba-transaminase deficiency,biolink:Pathway,SMP00351
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,glucose-alanine cycle,biolink:Pathway,SMP00127
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00250,glutamate metabolism,biolink:Pathway,SMP00072
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,glutaminolysis and cancer,biolink:Pathway,SMP02298
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,glutaric aciduria type i,biolink:Pathway,SMP00186
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00260,"glycine, serine and threonine metabolism",biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,glycogen storage disease type 1a (gsd1a) or von gierke disease,biolink:Pathway,SMP00374
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"glycogenosis, type ia. von gierke disease",biolink:Pathway,SMP00581
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"glycogenosis, type ib",biolink:Pathway,SMP00573
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"glycogenosis, type ic",biolink:Pathway,SMP00574
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00010,glycolysis / gluconeogenesis,biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,guanidinoacetate methyltransferase deficiency (gamt deficiency),biolink:Pathway,SMP00188
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,homocarnosinosis,biolink:Pathway,SMP00385
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"hyperglycinemia, non-ketotic",biolink:Pathway,SMP00485
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,hyperinsulinism-hyperammonemia syndrome,biolink:Pathway,SMP00339
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"hyperlysinemia i, familial",biolink:Pathway,SMP00527
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,hyperlysinemia ii or saccharopinuria,biolink:Pathway,SMP00528
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,hyperornithinemia with gyrate atrophy (hoga),biolink:Pathway,SMP00505
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,hyperornithinemia-hyperammonemia-homocitrullinuria [hhh-syndrome],biolink:Pathway,SMP00506
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,hyperprolinemia type i,biolink:Pathway,SMP00361
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,hyperprolinemia type ii,biolink:Pathway,SMP00360
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,hypoacetylaspartia,biolink:Pathway,SMP00192
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,isobutyryl-coa dehydrogenase deficiency,biolink:Pathway,SMP00523
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,isovaleric acidemia,biolink:Pathway,SMP00524
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,isovaleric aciduria,biolink:Pathway,SMP00238
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,l-arginine:glycine amidinotransferase deficiency,biolink:Pathway,SMP00507
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,lactic acidemia,biolink:Pathway,SMP00313
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00310,lysine degradation,biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,malate-aspartate shuttle,biolink:Pathway,SMP00129
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,malonic aciduria,biolink:Pathway,SMP00198
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,malonyl-coa decarboxylase deficiency,biolink:Pathway,SMP00502
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,maple syrup urine disease,biolink:Pathway,SMP00199
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,methylmalonate semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00384
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,methylmalonic aciduria,biolink:Pathway,SMP00200
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,methylmalonic aciduria due to cobalamin-related disorders,biolink:Pathway,SMP00201
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,mitochondrial complex ii deficiency,biolink:Pathway,SMP00548
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00910,nitrogen metabolism,biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,non ketotic hyperglycinemia,biolink:Pathway,SMP00223
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,ornithine aminotransferase deficiency (oat deficiency),biolink:Pathway,SMP00363
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,ornithine transcarbamylase deficiency (otc deficiency),biolink:Pathway,SMP00205
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,oxidation of branched chain fatty acids,biolink:Pathway,SMP00030
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00360,phenylalanine and tyrosine metabolism,biolink:Pathway,SMP00008
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,phenylketonuria,biolink:Pathway,SMP00206
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,phosphoenolpyruvate carboxykinase deficiency 1 (pepck1),biolink:Pathway,SMP00560
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,phytanic acid peroxisomal oxidation,biolink:Pathway,SMP00450
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,primary hyperoxaluria type i,biolink:Pathway,SMP00352
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,prolidase deficiency (pd),biolink:Pathway,SMP00207
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,prolinemia type ii,biolink:Pathway,SMP00208
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00640,propanoate metabolism,biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,propionic acidemia,biolink:Pathway,SMP00236
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,pyridoxine dependency with seizures,biolink:Pathway,SMP00571
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,pyruvate carboxylase deficiency,biolink:Pathway,SMP00350
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,pyruvate dehydrogenase deficiency (e2),biolink:Pathway,SMP00551
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,pyruvate dehydrogenase deficiency (e3),biolink:Pathway,SMP00550
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,refsum disease,biolink:Pathway,SMP00451
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,saccharopinuria/hyperlysinemia ii,biolink:Pathway,SMP00239
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,sarcosinemia,biolink:Pathway,SMP00244
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,succinic semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00567
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,the oncogenic action of 2-hydroxyglutarate,biolink:Pathway,SMP02291
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,the oncogenic action of d-2-hydroxyglutarate in  hydroxygluaricaciduria ,biolink:Pathway,SMP02359
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,the oncogenic action of fumarate,biolink:Pathway,SMP02295
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,the oncogenic action of l-2-hydroxyglutarate in  hydroxygluaricaciduria,biolink:Pathway,SMP02358
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,the oncogenic action of succinate,biolink:Pathway,SMP02292
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,triosephosphate isomerase,biolink:Pathway,SMP00563
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00380,tryptophan metabolism,biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,tyrosinemia type 2 (or richner-hanhart syndrome),biolink:Pathway,SMP00369
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,tyrosinemia type 3 (tyro3),biolink:Pathway,SMP00370
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00330,urea cycle,biolink:Pathway,SMP00059
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,ureidopropionase deficiency,biolink:Pathway,SMP00492
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,map00280,"valine, leucine and isoleucine degradation",biolink:Pathway,
19,KPGXRSRHYNQIFN-UHFFFAOYSA-N,,warburg effect,biolink:Pathway,SMP00654
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,3-methylthiofentanyl action pathway,biolink:Pathway,SMP00679
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,alfentanil action pathway,biolink:Pathway,SMP00413
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,alkaptonuria,biolink:Pathway,SMP00169
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,alvimopan action pathway,biolink:Pathway,SMP00685
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,anileridine action pathway,biolink:Pathway,SMP00674
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,aromatic l-aminoacid decarboxylase deficiency,biolink:Pathway,SMP00170
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,benzocaine action pathway,biolink:Pathway,SMP00392
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,bupivacaine action pathway,biolink:Pathway,SMP00393
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,buprenorphine action pathway,biolink:Pathway,SMP00684
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,carfentanil action pathway,biolink:Pathway,SMP00414
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,chloroprocaine action pathway,biolink:Pathway,SMP00394
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,citalopram action pathway,biolink:Pathway,SMP00424
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,cocaine action pathway,biolink:Pathway,SMP00395
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,codeine action pathway,biolink:Pathway,SMP00405
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,desipramine action pathway,biolink:Pathway,SMP00423
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,dezocine action pathway,biolink:Pathway,SMP00676
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,dibucaine action pathway,biolink:Pathway,SMP00396
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,dihydromorphine action pathway,biolink:Pathway,SMP00689
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,dimethylthiambutene action pathway,biolink:Pathway,SMP00680
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,diphenoxylate action pathway,biolink:Pathway,SMP00675
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,escitalopram action pathway,biolink:Pathway,SMP00425
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,ethylmorphine action pathway,biolink:Pathway,SMP00681
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,fentanyl action pathway,biolink:Pathway,SMP00415
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,fluoxetine action pathway,biolink:Pathway,SMP00426
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,heroin action pathway,biolink:Pathway,SMP00407
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,hydrocodone action pathway,biolink:Pathway,SMP00411
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,hydromorphone action pathway,biolink:Pathway,SMP00410
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,imipramine action pathway,biolink:Pathway,SMP00422
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,ketobemidone  action pathway,biolink:Pathway,SMP00690
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,levallorphan action pathway,biolink:Pathway,SMP00683
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,levobupivacaine action pathway,biolink:Pathway,SMP00397
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,levomethadyl acetate action action pathway,biolink:Pathway,SMP00677
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,levorphanol action pathway,biolink:Pathway,SMP00673
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,lidocaine (local anaesthetic) action pathway,biolink:Pathway,SMP00398
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,mepivacaine action pathway,biolink:Pathway,SMP00399
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,methadone action pathway,biolink:Pathway,SMP00408
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,methadyl acetate action pathway,biolink:Pathway,SMP00678
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,morphine action pathway,biolink:Pathway,SMP00406
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,nalbuphine action pathway,biolink:Pathway,SMP00691
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,naloxone action pathway,biolink:Pathway,SMP00688
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,naltrexone action pathway,biolink:Pathway,SMP00687
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,nicotine action pathway,biolink:Pathway,SMP00431
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,oxybuprocaine action pathway,biolink:Pathway,SMP00400
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,oxycodone action pathway,biolink:Pathway,SMP00409
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,oxymorphone action pathway,biolink:Pathway,SMP00412
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,pentazocine action pathway,biolink:Pathway,SMP00686
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,prilocaine action pathway,biolink:Pathway,SMP00401
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,procaine action pathway,biolink:Pathway,SMP00402
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,proparacaine action pathway,biolink:Pathway,SMP00403
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,propoxyphene action pathway,biolink:Pathway,SMP00672
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,remifentanil action pathway,biolink:Pathway,SMP00416
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,ropivacaine action pathway,biolink:Pathway,SMP00404
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,sufentanil action pathway,biolink:Pathway,SMP00417
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,tramadol action action pathway,biolink:Pathway,SMP00671
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,tyrosine hydroxylase deficiency,biolink:Pathway,SMP00497
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,map00350,tyrosine metabolism,biolink:Pathway,
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,map00350,tyrosine metabolism,biolink:Pathway,
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
20,SFLSHLFXELFNJZ-QMMMGPOBSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
21,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,,sulfite oxidase deficiency,biolink:Pathway,SMP00532
21,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,map00920,sulfur metabolism,biolink:Pathway,
22,XBDQKXXYIPTUBI-UHFFFAOYSA-N,,malonic aciduria,biolink:Pathway,SMP00198
22,XBDQKXXYIPTUBI-UHFFFAOYSA-N,,malonyl-coa decarboxylase deficiency,biolink:Pathway,SMP00502
22,XBDQKXXYIPTUBI-UHFFFAOYSA-N,,methylmalonic aciduria due to cobalamin-related disorders,biolink:Pathway,SMP00201
22,XBDQKXXYIPTUBI-UHFFFAOYSA-N,map00640,propanoate metabolism,biolink:Pathway,
22,XBDQKXXYIPTUBI-UHFFFAOYSA-N,,vitamin k metabolism,biolink:Pathway,SMP00464
23,LCTONWCANYUPML-UHFFFAOYSA-N,,2-hydroxyglutric aciduria (d and l form),biolink:Pathway,SMP00136
23,LCTONWCANYUPML-UHFFFAOYSA-N,,2-ketoglutarate dehydrogenase complex deficiency,biolink:Pathway,SMP00549
23,LCTONWCANYUPML-UHFFFAOYSA-N,,3-phosphoglycerate dehydrogenase deficiency,biolink:Pathway,SMP00721
23,LCTONWCANYUPML-UHFFFAOYSA-N,,4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00243
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00250,"alanine, aspartate and glutamate metabolism",biolink:Pathway,
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00520,amino sugar metabolism,biolink:Pathway,SMP00045
23,LCTONWCANYUPML-UHFFFAOYSA-N,,argininemia,biolink:Pathway,SMP00357
23,LCTONWCANYUPML-UHFFFAOYSA-N,,argininosuccinic aciduria,biolink:Pathway,SMP00003
23,LCTONWCANYUPML-UHFFFAOYSA-N,,beta-mercaptolactate-cysteine disulfiduria,biolink:Pathway,SMP00499
23,LCTONWCANYUPML-UHFFFAOYSA-N,,carbamoyl phosphate synthetase deficiency,biolink:Pathway,SMP00002
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00020,citric acid cycle,biolink:Pathway,SMP00057
23,LCTONWCANYUPML-UHFFFAOYSA-N,,citrullinemia type i,biolink:Pathway,SMP00001
23,LCTONWCANYUPML-UHFFFAOYSA-N,,congenital lactic acidosis,biolink:Pathway,SMP00546
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00270,cysteine metabolism,biolink:Pathway,SMP00013
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"cystinosis, ocular nonnephropathic",biolink:Pathway,SMP00722
23,LCTONWCANYUPML-UHFFFAOYSA-N,,dihydropyrimidine dehydrogenase deficiency (dhpd),biolink:Pathway,SMP00179
23,LCTONWCANYUPML-UHFFFAOYSA-N,,dimethylglycine dehydrogenase deficiency,biolink:Pathway,SMP00242
23,LCTONWCANYUPML-UHFFFAOYSA-N,,dimethylglycine dehydrogenase deficiency,biolink:Pathway,SMP00484
23,LCTONWCANYUPML-UHFFFAOYSA-N,,fanconi-bickel syndrome,biolink:Pathway,SMP00572
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"fructose-1,6-diphosphatase deficiency",biolink:Pathway,SMP00562
23,LCTONWCANYUPML-UHFFFAOYSA-N,,fumarase deficiency,biolink:Pathway,SMP00547
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"g(m2)-gangliosidosis: variant b, tay-sachs disease",biolink:Pathway,SMP00534
23,LCTONWCANYUPML-UHFFFAOYSA-N,,glucose-alanine cycle,biolink:Pathway,SMP00127
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00250,glutamate metabolism,biolink:Pathway,SMP00072
23,LCTONWCANYUPML-UHFFFAOYSA-N,,glutaminolysis and cancer,biolink:Pathway,SMP02298
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00260,"glycine, serine and threonine metabolism",biolink:Pathway,
23,LCTONWCANYUPML-UHFFFAOYSA-N,,glycogen storage disease type 1a (gsd1a) or von gierke disease,biolink:Pathway,SMP00374
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"glycogenosis, type ia. von gierke disease",biolink:Pathway,SMP00581
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"glycogenosis, type ib",biolink:Pathway,SMP00573
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"glycogenosis, type ic",biolink:Pathway,SMP00574
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"glycogenosis, type vii. tarui disease",biolink:Pathway,SMP00531
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00010,glycolysis / gluconeogenesis,biolink:Pathway,
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00010,glycolysis / gluconeogenesis,biolink:Pathway,
23,LCTONWCANYUPML-UHFFFAOYSA-N,,homocarnosinosis,biolink:Pathway,SMP00385
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"hyperglycinemia, non-ketotic",biolink:Pathway,SMP00485
23,LCTONWCANYUPML-UHFFFAOYSA-N,,hyperinsulinism-hyperammonemia syndrome,biolink:Pathway,SMP00339
23,LCTONWCANYUPML-UHFFFAOYSA-N,,lactic acidemia,biolink:Pathway,SMP00313
23,LCTONWCANYUPML-UHFFFAOYSA-N,,leigh syndrome,biolink:Pathway,SMP00196
23,LCTONWCANYUPML-UHFFFAOYSA-N,,mitochondrial complex ii deficiency,biolink:Pathway,SMP00548
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00910,nitrogen metabolism,biolink:Pathway,
23,LCTONWCANYUPML-UHFFFAOYSA-N,,non ketotic hyperglycinemia,biolink:Pathway,SMP00223
23,LCTONWCANYUPML-UHFFFAOYSA-N,,ornithine transcarbamylase deficiency (otc deficiency),biolink:Pathway,SMP00205
23,LCTONWCANYUPML-UHFFFAOYSA-N,,phosphoenolpyruvate carboxykinase deficiency 1 (pepck1),biolink:Pathway,SMP00560
23,LCTONWCANYUPML-UHFFFAOYSA-N,,"primary hyperoxaluria ii, ph2",biolink:Pathway,SMP00558
23,LCTONWCANYUPML-UHFFFAOYSA-N,,primary hyperoxaluria type i,biolink:Pathway,SMP00352
23,LCTONWCANYUPML-UHFFFAOYSA-N,,pyruvaldehyde degradation,biolink:Pathway,SMP00459
23,LCTONWCANYUPML-UHFFFAOYSA-N,,pyruvate carboxylase deficiency,biolink:Pathway,SMP00350
23,LCTONWCANYUPML-UHFFFAOYSA-N,,pyruvate decarboxylase e1 component deficiency (pdhe1 deficiency),biolink:Pathway,SMP00334
23,LCTONWCANYUPML-UHFFFAOYSA-N,,pyruvate dehydrogenase complex deficiency,biolink:Pathway,SMP00212
23,LCTONWCANYUPML-UHFFFAOYSA-N,,pyruvate dehydrogenase deficiency (e2),biolink:Pathway,SMP00551
23,LCTONWCANYUPML-UHFFFAOYSA-N,,pyruvate dehydrogenase deficiency (e3),biolink:Pathway,SMP00550
23,LCTONWCANYUPML-UHFFFAOYSA-N,,pyruvate kinase deficiency,biolink:Pathway,SMP00559
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00620,pyruvate metabolism,biolink:Pathway,
23,LCTONWCANYUPML-UHFFFAOYSA-N,,salla disease/infantile sialic acid storage disease,biolink:Pathway,SMP00240
23,LCTONWCANYUPML-UHFFFAOYSA-N,,sarcosinemia,biolink:Pathway,SMP00244
23,LCTONWCANYUPML-UHFFFAOYSA-N,,sialuria or french type sialuria,biolink:Pathway,SMP00216
23,LCTONWCANYUPML-UHFFFAOYSA-N,,succinic semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00567
23,LCTONWCANYUPML-UHFFFAOYSA-N,,tay-sachs disease,biolink:Pathway,SMP00390
23,LCTONWCANYUPML-UHFFFAOYSA-N,,the oncogenic action of 2-hydroxyglutarate,biolink:Pathway,SMP02291
23,LCTONWCANYUPML-UHFFFAOYSA-N,,the oncogenic action of d-2-hydroxyglutarate in  hydroxygluaricaciduria ,biolink:Pathway,SMP02359
23,LCTONWCANYUPML-UHFFFAOYSA-N,,the oncogenic action of fumarate,biolink:Pathway,SMP02295
23,LCTONWCANYUPML-UHFFFAOYSA-N,,the oncogenic action of l-2-hydroxyglutarate in  hydroxygluaricaciduria,biolink:Pathway,SMP02358
23,LCTONWCANYUPML-UHFFFAOYSA-N,,the oncogenic action of succinate,biolink:Pathway,SMP02292
23,LCTONWCANYUPML-UHFFFAOYSA-N,,transfer of acetyl groups into mitochondria,biolink:Pathway,SMP00466
23,LCTONWCANYUPML-UHFFFAOYSA-N,,triosephosphate isomerase,biolink:Pathway,SMP00563
23,LCTONWCANYUPML-UHFFFAOYSA-N,map00330,urea cycle,biolink:Pathway,SMP00059
23,LCTONWCANYUPML-UHFFFAOYSA-N,,warburg effect,biolink:Pathway,SMP00654
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,2-hydroxyglutric aciduria (d and l form),biolink:Pathway,SMP00136
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,2-ketoglutarate dehydrogenase complex deficiency,biolink:Pathway,SMP00549
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,2-methyl-3-hydroxybutryl coa dehydrogenase deficiency,biolink:Pathway,SMP00137
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,3-hydroxy-3-methylglutaryl-coa lyase deficiency,biolink:Pathway,SMP00138
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,3-hydroxyisobutyric acid dehydrogenase deficiency,biolink:Pathway,SMP00521
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,3-hydroxyisobutyric aciduria,biolink:Pathway,SMP00522
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,3-methylcrotonyl coa carboxylase deficiency type i,biolink:Pathway,SMP00237
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,3-methylglutaconic aciduria type i,biolink:Pathway,SMP00139
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,3-methylglutaconic aciduria type iii,biolink:Pathway,SMP00140
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,3-methylglutaconic aciduria type iv,biolink:Pathway,SMP00141
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00243
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,map00330,arginine and proline metabolism,biolink:Pathway,
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,arginine: glycine amidinotransferase deficiency (agat deficiency),biolink:Pathway,SMP00362
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,beta-ketothiolase deficiency,biolink:Pathway,SMP00173
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,map00650,butyrate metabolism,biolink:Pathway,SMP00073
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,carnitine synthesis,biolink:Pathway,SMP00465
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,map00020,citric acid cycle,biolink:Pathway,SMP00057
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,congenital lactic acidosis,biolink:Pathway,SMP00546
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,"creatine deficiency, guanidinoacetate methyltransferase deficiency",biolink:Pathway,SMP00504
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,fumarase deficiency,biolink:Pathway,SMP00547
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,map00250,glutamate metabolism,biolink:Pathway,SMP00072
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,glutaminolysis and cancer,biolink:Pathway,SMP02298
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,guanidinoacetate methyltransferase deficiency (gamt deficiency),biolink:Pathway,SMP00188
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,homocarnosinosis,biolink:Pathway,SMP00385
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,hyperinsulinism-hyperammonemia syndrome,biolink:Pathway,SMP00339
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,hyperornithinemia with gyrate atrophy (hoga),biolink:Pathway,SMP00505
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,hyperornithinemia-hyperammonemia-homocitrullinuria [hhh-syndrome],biolink:Pathway,SMP00506
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,hyperprolinemia type i,biolink:Pathway,SMP00361
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,hyperprolinemia type ii,biolink:Pathway,SMP00360
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,isobutyryl-coa dehydrogenase deficiency,biolink:Pathway,SMP00523
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,isovaleric acidemia,biolink:Pathway,SMP00524
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,isovaleric aciduria,biolink:Pathway,SMP00238
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,map00072,ketone body metabolism,biolink:Pathway,SMP00071
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,l-arginine:glycine amidinotransferase deficiency,biolink:Pathway,SMP00507
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,maple syrup urine disease,biolink:Pathway,SMP00199
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,methylmalonate semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00384
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,methylmalonic aciduria,biolink:Pathway,SMP00200
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,mitochondrial complex ii deficiency,biolink:Pathway,SMP00548
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,ornithine aminotransferase deficiency (oat deficiency),biolink:Pathway,SMP00363
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,oxidation of branched chain fatty acids,biolink:Pathway,SMP00030
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,map00190,oxidative phosphorylation,biolink:Pathway,
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,phytanic acid peroxisomal oxidation,biolink:Pathway,SMP00450
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,prolidase deficiency (pd),biolink:Pathway,SMP00207
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,prolinemia type ii,biolink:Pathway,SMP00208
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,propionic acidemia,biolink:Pathway,SMP00236
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,pyruvate dehydrogenase deficiency (e2),biolink:Pathway,SMP00551
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,pyruvate dehydrogenase deficiency (e3),biolink:Pathway,SMP00550
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,refsum disease,biolink:Pathway,SMP00451
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,succinic semialdehyde dehydrogenase deficiency,biolink:Pathway,SMP00567
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,succinyl coa: 3-ketoacid coa transferase deficiency,biolink:Pathway,SMP00569
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,the oncogenic action of 2-hydroxyglutarate,biolink:Pathway,SMP02291
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,the oncogenic action of d-2-hydroxyglutarate in  hydroxygluaricaciduria ,biolink:Pathway,SMP02359
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,the oncogenic action of fumarate,biolink:Pathway,SMP02295
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,the oncogenic action of l-2-hydroxyglutarate in  hydroxygluaricaciduria,biolink:Pathway,SMP02358
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,the oncogenic action of succinate,biolink:Pathway,SMP02292
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,map00280,"valine, leucine and isoleucine degradation",biolink:Pathway,
24,KDYFGRWQOYBRFD-UHFFFAOYSA-N,,warburg effect,biolink:Pathway,SMP00654
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,3-methylthiofentanyl action pathway,biolink:Pathway,SMP00679
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,alfentanil action pathway,biolink:Pathway,SMP00413
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,alvimopan action pathway,biolink:Pathway,SMP00685
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,anileridine action pathway,biolink:Pathway,SMP00674
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,benzocaine action pathway,biolink:Pathway,SMP00392
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,bupivacaine action pathway,biolink:Pathway,SMP00393
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,buprenorphine action pathway,biolink:Pathway,SMP00684
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,carfentanil action pathway,biolink:Pathway,SMP00414
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,chloroprocaine action pathway,biolink:Pathway,SMP00394
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,citalopram action pathway,biolink:Pathway,SMP00424
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,cocaine action pathway,biolink:Pathway,SMP00395
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,codeine action pathway,biolink:Pathway,SMP00405
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,desipramine action pathway,biolink:Pathway,SMP00423
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,dezocine action pathway,biolink:Pathway,SMP00676
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,dibucaine action pathway,biolink:Pathway,SMP00396
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,dihydromorphine action pathway,biolink:Pathway,SMP00689
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,dimethylthiambutene action pathway,biolink:Pathway,SMP00680
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,diphenoxylate action pathway,biolink:Pathway,SMP00675
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,escitalopram action pathway,biolink:Pathway,SMP00425
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,ethylmorphine action pathway,biolink:Pathway,SMP00681
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,excitatory neural signalling through 5-htr 4 and serotonin,biolink:Pathway,SMP00309
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,excitatory neural signalling through 5-htr 6 and serotonin,biolink:Pathway,SMP00312
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,excitatory neural signalling through 5-htr 7 and serotonin,biolink:Pathway,SMP00311
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,fentanyl action pathway,biolink:Pathway,SMP00415
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,fluoxetine action pathway,biolink:Pathway,SMP00426
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,heroin action pathway,biolink:Pathway,SMP00407
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,hydrocodone action pathway,biolink:Pathway,SMP00411
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,hydromorphone action pathway,biolink:Pathway,SMP00410
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,imipramine action pathway,biolink:Pathway,SMP00422
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,ketobemidone  action pathway,biolink:Pathway,SMP00690
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,levallorphan action pathway,biolink:Pathway,SMP00683
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,levobupivacaine action pathway,biolink:Pathway,SMP00397
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,levomethadyl acetate action action pathway,biolink:Pathway,SMP00677
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,levorphanol action pathway,biolink:Pathway,SMP00673
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,lidocaine (local anaesthetic) action pathway,biolink:Pathway,SMP00398
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,mepivacaine action pathway,biolink:Pathway,SMP00399
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,methadone action pathway,biolink:Pathway,SMP00408
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,methadyl acetate action pathway,biolink:Pathway,SMP00678
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,morphine action pathway,biolink:Pathway,SMP00406
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,nalbuphine action pathway,biolink:Pathway,SMP00691
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,naloxone action pathway,biolink:Pathway,SMP00688
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,naltrexone action pathway,biolink:Pathway,SMP00687
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,nicotine action pathway,biolink:Pathway,SMP00431
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,oxybuprocaine action pathway,biolink:Pathway,SMP00400
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,oxycodone action pathway,biolink:Pathway,SMP00409
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,oxymorphone action pathway,biolink:Pathway,SMP00412
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,pentazocine action pathway,biolink:Pathway,SMP00686
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,prilocaine action pathway,biolink:Pathway,SMP00401
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,procaine action pathway,biolink:Pathway,SMP00402
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,proparacaine action pathway,biolink:Pathway,SMP00403
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,propoxyphene action pathway,biolink:Pathway,SMP00672
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,remifentanil action pathway,biolink:Pathway,SMP00416
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,ropivacaine action pathway,biolink:Pathway,SMP00404
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,sufentanil action pathway,biolink:Pathway,SMP00417
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,,tramadol action action pathway,biolink:Pathway,SMP00671
25,QZAYGJVTTNCVMB-UHFFFAOYSA-N,map00380,tryptophan metabolism,biolink:Pathway,
26,DZGWFCGJZKJUFP-UHFFFAOYSA-N,,alkaptonuria,biolink:Pathway,SMP00169
26,DZGWFCGJZKJUFP-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
26,DZGWFCGJZKJUFP-UHFFFAOYSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
26,DZGWFCGJZKJUFP-UHFFFAOYSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
26,DZGWFCGJZKJUFP-UHFFFAOYSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
26,DZGWFCGJZKJUFP-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
26,DZGWFCGJZKJUFP-UHFFFAOYSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
26,DZGWFCGJZKJUFP-UHFFFAOYSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
27,DZAIOXUZHHTJKN-UHFFFAOYSA-N,,,,
28,QVWAEZJXDYOKEH-UHFFFAOYSA-N,,,,
29,MUCMKTPAZLSKTL-NSHDSACASA-N,,,,
30,BITYXLXUCSKTJS-ZETCQYMHSA-N,,,,
31,DZAUWHJDUNRCTF-UHFFFAOYSA-N,,,,
32,XFTRTWQBIOMVPK-UHFFFAOYSA-N,,,,
33,FVMDYYGIDFPZAX-UHFFFAOYSA-N,,,,
34,WNLRTRBMVRJNCN-UHFFFAOYSA-N,,,,
35,POJWUDADGALRAB-UHFFFAOYSA-N,,,,
36,ZFRKQXVRDFCRJG-UHFFFAOYSA-N,,,,
37,WKOLLVMJNQIZCI-UHFFFAOYSA-N,,,,
38,FJKROLUGYXJWQN-UHFFFAOYSA-N,map00130,ubiquinone biosynthesis,biolink:Pathway,SMP00065
39,QYIXCDOBOSTCEI-NWKZBHTNSA-N,,,,
40,LQXVFWRQNMEDEE-UOWFLXDJSA-N,,,,
41,SRBFZHDQGSBBOR-KLVWXMOXSA-N,,,,
42,JFCQEDHGNNZCLN-UHFFFAOYSA-N,,,,
43,XGILAAMKEQUXLS-JTQLQIEISA-N,,,,
44,BXFFHSIDQOFMLE-UHFFFAOYSA-N,,,,
45,ALRHLSYJTWAHJZ-UHFFFAOYSA-N,,malonic aciduria,biolink:Pathway,SMP00198
45,ALRHLSYJTWAHJZ-UHFFFAOYSA-N,,malonyl-coa decarboxylase deficiency,biolink:Pathway,SMP00502
45,ALRHLSYJTWAHJZ-UHFFFAOYSA-N,,methylmalonic aciduria due to cobalamin-related disorders,biolink:Pathway,SMP00201
45,ALRHLSYJTWAHJZ-UHFFFAOYSA-N,map00640,propanoate metabolism,biolink:Pathway,
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,alkaptonuria,biolink:Pathway,SMP00169
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,map00360,phenylalanine and tyrosine metabolism,biolink:Pathway,SMP00008
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,phenylketonuria,biolink:Pathway,SMP00206
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,tyrosinemia type 2 (or richner-hanhart syndrome),biolink:Pathway,SMP00369
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,tyrosinemia type 3 (tyro3),biolink:Pathway,SMP00370
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
46,KKADPXVIOXHVKN-UHFFFAOYSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
47,SJZRECIVHVDYJC-UHFFFAOYSA-N,,,,
48,QIAFMBKCNZACKA-UHFFFAOYSA-N,,,,
49,PLVPPLCLBIEYEA-AATRIKPKSA-N,,,,
50,SIKJAQJRHWYJAI-UHFFFAOYSA-N,,,,
51,LVRFTAZAXQPQHI-YFKPBYRVSA-N,,,,
52,JVGVDSSUAVXRDY-UHFFFAOYSA-N,,,,
53,DUUGKQCEGZLZNO-UHFFFAOYSA-N,map00380,tryptophan metabolism,biolink:Pathway,
54,XMIIGOLPHOKFCH-UHFFFAOYSA-N,,,,
55,FBPFZTCFMRRESA-KVTDHHQDSA-N,,,,
56,ISYWECDDZWTKFF-UHFFFAOYSA-N,,,,
57,VOXXWSYKYCBWHO-UHFFFAOYSA-N,,,,
58,BDERNNFJNOPAEC-UHFFFAOYSA-N,,sulfite oxidase deficiency,biolink:Pathway,SMP00532
58,BDERNNFJNOPAEC-UHFFFAOYSA-N,map00920,sulfur metabolism,biolink:Pathway,
59,SHZGCJCMOBCMKK-JFNONXLTSA-N,,,,
60,KFZMGEQAYNKOFK-UHFFFAOYSA-N,,,,
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,acrivastine h1-antihistamine action,biolink:Pathway,SMP59881
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,alcaftadine h1-antihistamine action,biolink:Pathway,SMP62881
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,alimemazine h1-antihistamine action,biolink:Pathway,SMP59689
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,antazoline h1-antihistamine action,biolink:Pathway,SMP57584
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,astemizole h1-antihistamine action,biolink:Pathway,SMP59897
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,azatadine h1-antihistamine action,biolink:Pathway,SMP59865
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,azelastine h1-antihistamine action,biolink:Pathway,SMP60741
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,bamipine h1-antihistamine action,biolink:Pathway,SMP62882
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,bepotastine h1-antihistamine action,biolink:Pathway,SMP60058
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,betahistine h1-antihistamine action,biolink:Pathway,SMP60744
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,betazole action pathway,biolink:Pathway,SMP00736
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,bilastine h1-antihistamine action,biolink:Pathway,SMP60170
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,bromodiphenhydramine h1-antihistamine action,biolink:Pathway,SMP58813
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,brompheniramine h1-antihistamine action,biolink:Pathway,SMP57579
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,buclizine h1-antihistamine action,biolink:Pathway,SMP58964
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,carbinoxamine h1-antihistamine action,biolink:Pathway,SMP58797
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,cetirizine h1-antihistamine action,biolink:Pathway,SMP59058
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,chlorcyclizine h1-antihistamine action,biolink:Pathway,SMP58931
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,chloropyramine h1-antihistamine action,biolink:Pathway,SMP57585
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,chlorphenamine h1-antihistamine action,biolink:Pathway,SMP56661
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,chlorphenoxamine h1-antihistamine action,biolink:Pathway,SMP58903
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,cimetidine action pathway,biolink:Pathway,SMP00232
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,cinnarizine h1-antihistamine action,biolink:Pathway,SMP59110
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,clemastine h1-antihistamine action,biolink:Pathway,SMP58891
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,clocinizine h1-antihistamine action,biolink:Pathway,SMP62788
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,cyclizine h1-antihistamine action,biolink:Pathway,SMP58923
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,cyproheptadine h1-antihistamine action,biolink:Pathway,SMP59694
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,deptropine h1-antihistamine action,biolink:Pathway,SMP62883
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,desloratadine h1-antihistamine action,biolink:Pathway,SMP60201
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,dexbrompheniramine h1-antihistamine action,biolink:Pathway,SMP57580
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,dexchlorpheniramine h1-antihistamine action,biolink:Pathway,SMP56811
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,dimetindene h1-antihistamine action,biolink:Pathway,SMP57582
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,diphenhydramine h1-antihistamine action,biolink:Pathway,SMP58785
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,diphenylpyraline h1-antihistamine action,biolink:Pathway,SMP58908
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,doxepin h1-antihistamine action,biolink:Pathway,SMP59872
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,doxylamine h1-antihistamine action,biolink:Pathway,SMP58803
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,ebastine h1-antihistamine action,biolink:Pathway,SMP60204
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,embramine h1-antihistamine action,biolink:Pathway,SMP62622
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,emedastine h1-antihistamine action,biolink:Pathway,SMP61040
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,epinastine h1-antihistamine action,biolink:Pathway,SMP61191
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,esomeprazole action pathway,biolink:Pathway,SMP00225
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,famotidine action pathway,biolink:Pathway,SMP00231
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,fc epsilon receptor i signaling in mast cells,biolink:Pathway,SMP00358
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,fenethazine h1-antihistamine action,biolink:Pathway,SMP59707
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,fexofenadine h1-antihistamine action,biolink:Pathway,SMP60218
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,flunarizine h1-antihistamine action,biolink:Pathway,SMP61047
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,gastric acid production,biolink:Pathway,SMP00589
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,histamine h1 receptor activation,biolink:Pathway,SMP53896
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,histamine h1 receptor activation,biolink:Pathway,SMP63452
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,histapyrrodine h1-antihistamine action,biolink:Pathway,SMP58732
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,map00340,histidine metabolism,biolink:Pathway,SMP00044
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,histidinemia,biolink:Pathway,SMP00191
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,homochlorcyclizine h1-antihistamine action,biolink:Pathway,SMP62795
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,hydroxyethylpromethazine h1-antihistamine action,biolink:Pathway,SMP59710
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,hydroxyzine h1-antihistamine action,biolink:Pathway,SMP58936
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,intracellular signalling through histamine h2 receptor and histamine,biolink:Pathway,SMP00335
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,isothipendyl h1-antihistamine action,biolink:Pathway,SMP59716
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,ketotifen h1-antihistamine action,biolink:Pathway,SMP59868
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,lafutidine h2-antihistamine action,biolink:Pathway,SMP51038
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,lansoprazole action pathway,biolink:Pathway,SMP00227
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,latrepirdine h1-antihistamine action,biolink:Pathway,SMP62623
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,levocabastine h1-antihistamine action,biolink:Pathway,SMP60224
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,levocetirizine h1-antihistamine action,biolink:Pathway,SMP59114
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,loratadine h1-antihistamine action,biolink:Pathway,SMP60195
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,mebhydrolin h1-antihistamine action,biolink:Pathway,SMP61052
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,meclizine h1-antihistamine action,biolink:Pathway,SMP58956
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,mepyramine h1-antihistamine action,biolink:Pathway,SMP57583
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,mequitazine h1-antihistamine action,biolink:Pathway,SMP59720
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,methapyrilene h1-antihistamine action,biolink:Pathway,SMP58741
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,methdilazine h1-antihistamine action,biolink:Pathway,SMP59730
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,metiamide action pathway,biolink:Pathway,SMP00735
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,mirtazapine h1-antihistamine action,biolink:Pathway,SMP62885
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,mizolastine h1-antihistamine action,biolink:Pathway,SMP60230
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,nizatidine action pathway,biolink:Pathway,SMP00233
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,olopatadine h1-antihistamine action,biolink:Pathway,SMP60740
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,omeprazole action pathway,biolink:Pathway,SMP00226
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,orphenadrine h1-antihistamine action,biolink:Pathway,SMP58808
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,oxatomide h1-antihistamine action,biolink:Pathway,SMP59044
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,oxomemazine h1-antihistamine action,biolink:Pathway,SMP59738
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,pantoprazole action pathway,biolink:Pathway,SMP00228
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,phenbenzamine h1-antihistamine action,biolink:Pathway,SMP59702
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,phenindamine h1-antihistamine action,biolink:Pathway,SMP61190
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,pheniramine h1-antihistamine action,biolink:Pathway,SMP56662
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,phenyltoloxamine h1-antihistamine action,biolink:Pathway,SMP58916
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,pimethixene h1-antihistamine action,biolink:Pathway,SMP62886
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,pirenzepine action pathway,biolink:Pathway,SMP00246
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,promethazine h1-antihistamine action,biolink:Pathway,SMP59211
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,propiomazine h1-antihistamine action,biolink:Pathway,SMP62625
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,pyrrobutamine h1-antihistamine action,biolink:Pathway,SMP62887
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,quetiapine h1-antihistamine action,biolink:Pathway,SMP62884
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,quifenadine h1-antihistamine action,biolink:Pathway,SMP60743
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,rabeprazole action pathway,biolink:Pathway,SMP00229
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,ranitidine action pathway,biolink:Pathway,SMP00230
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,roxatidine acetate action pathway,biolink:Pathway,SMP00734
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,rupatadine h1-antihistamine action,biolink:Pathway,SMP60235
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,talastine h1-antihistamine action,biolink:Pathway,SMP57586
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,temelastine h1-antihistamine action,biolink:Pathway,SMP62880
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,terfenadine h1-antihistamine action,biolink:Pathway,SMP60208
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,thenalidine h1-antihistamine action,biolink:Pathway,SMP62894
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,thenyldiamine h1-antihistamine action,biolink:Pathway,SMP62624
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,thiazinamium h1-antihistamine action,biolink:Pathway,SMP60742
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,thonzylamine h1-antihistamine action,biolink:Pathway,SMP58769
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,tolpropamine h1-antihistamine action,biolink:Pathway,SMP62621
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,tripelennamine h1-antihistamine action,biolink:Pathway,SMP57587
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,triprolidine h1-antihistamine action,biolink:Pathway,SMP57581
61,NTYJJOPFIAHURM-UHFFFAOYSA-N,,tritoqualine h1-antihistamine action,biolink:Pathway,SMP62895
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,betazole action pathway,biolink:Pathway,SMP00736
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,cimetidine action pathway,biolink:Pathway,SMP00232
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,esomeprazole action pathway,biolink:Pathway,SMP00225
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,famotidine action pathway,biolink:Pathway,SMP00231
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,gastric acid production,biolink:Pathway,SMP00589
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,lafutidine h2-antihistamine action,biolink:Pathway,SMP51038
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,lansoprazole action pathway,biolink:Pathway,SMP00227
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,metiamide action pathway,biolink:Pathway,SMP00735
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,nizatidine action pathway,biolink:Pathway,SMP00233
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,omeprazole action pathway,biolink:Pathway,SMP00226
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,pantoprazole action pathway,biolink:Pathway,SMP00228
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,map00564,phospholipid biosynthesis,biolink:Pathway,SMP00025
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,pirenzepine action pathway,biolink:Pathway,SMP00246
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,rabeprazole action pathway,biolink:Pathway,SMP00229
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,ranitidine action pathway,biolink:Pathway,SMP00230
62,OIPILFWXSMYKGL-UHFFFAOYSA-N,,roxatidine acetate action pathway,biolink:Pathway,SMP00734
63,AWDRATDZQPNJFN-VAYUFCLWSA-N,,27-hydroxylase deficiency,biolink:Pathway,SMP00720
63,AWDRATDZQPNJFN-VAYUFCLWSA-N,,cerebrotendinous xanthomatosis (ctx),biolink:Pathway,SMP00315
63,AWDRATDZQPNJFN-VAYUFCLWSA-N,,congenital bile acid synthesis defect type ii,biolink:Pathway,SMP00314
63,AWDRATDZQPNJFN-VAYUFCLWSA-N,,congenital bile acid synthesis defect type iii,biolink:Pathway,SMP00318
63,AWDRATDZQPNJFN-VAYUFCLWSA-N,,familial hypercholanemia (fhca),biolink:Pathway,SMP00317
63,AWDRATDZQPNJFN-VAYUFCLWSA-N,map00120,primary bile acid biosynthesis,biolink:Pathway,
63,AWDRATDZQPNJFN-VAYUFCLWSA-N,,zellweger syndrome,biolink:Pathway,SMP00316
64,GETQZCLCWQTVFV-UHFFFAOYSA-N,,,,
65,UYPYRKYUKCHHIB-UHFFFAOYSA-N,,,,
66,WBYWAXJHAXSJNI-VOTSOKGWSA-N,,,,
67,KSEBMYQBYZTDHS-HWKANZROSA-N,,,,
68,FEWJPZIEWOKRBE-JCYAYHJZSA-N,,,,
69,YCIMNLLNPGFGHC-UHFFFAOYSA-N,,alkaptonuria,biolink:Pathway,SMP00169
69,YCIMNLLNPGFGHC-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
69,YCIMNLLNPGFGHC-UHFFFAOYSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
69,YCIMNLLNPGFGHC-UHFFFAOYSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
69,YCIMNLLNPGFGHC-UHFFFAOYSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
69,YCIMNLLNPGFGHC-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
69,YCIMNLLNPGFGHC-UHFFFAOYSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
69,YCIMNLLNPGFGHC-UHFFFAOYSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
70,HDTRYLNUVZCQOY-LIZSDCNHSA-N,,trehalose degradation,biolink:Pathway,SMP00467
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,ethanol degradation,biolink:Pathway,SMP00449
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,glucose-6-phosphate dehydrogenase deficiency,biolink:Pathway,SMP00518
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,leigh syndrome,biolink:Pathway,SMP00196
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,pentose phosphate pathway,biolink:Pathway,
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,"primary hyperoxaluria ii, ph2",biolink:Pathway,SMP00558
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,pyruvate decarboxylase e1 component deficiency (pdhe1 deficiency),biolink:Pathway,SMP00334
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,pyruvate dehydrogenase complex deficiency,biolink:Pathway,SMP00212
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,pyruvate kinase deficiency,biolink:Pathway,SMP00559
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,map00620,pyruvate metabolism,biolink:Pathway,
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,ribose-5-phosphate isomerase deficiency,biolink:Pathway,SMP00519
71,IKHGUXGNUITLKF-UHFFFAOYSA-N,,transaldolase deficiency,biolink:Pathway,SMP00520
72,PYUSHNKNPOHWEZ-YFKPBYRVSA-N,,,,
73,OLVVOVIFTBSBBH-KVTDHHQDSA-N,,,,
74,LABSPYBHMPDTEL-LIZSDCNHSA-N,,,,
75,OVRNDRQMDRJTHS-OZRXBMAMSA-N,map00520,amino sugar metabolism,biolink:Pathway,SMP00045
75,OVRNDRQMDRJTHS-OZRXBMAMSA-N,,"g(m2)-gangliosidosis: variant b, tay-sachs disease",biolink:Pathway,SMP00534
75,OVRNDRQMDRJTHS-OZRXBMAMSA-N,,salla disease/infantile sialic acid storage disease,biolink:Pathway,SMP00240
75,OVRNDRQMDRJTHS-OZRXBMAMSA-N,,sialuria or french type sialuria,biolink:Pathway,SMP00216
75,OVRNDRQMDRJTHS-OZRXBMAMSA-N,,tay-sachs disease,biolink:Pathway,SMP00390
76,XTOKIEIBKARFSZ-LURJTMIESA-N,,,,
77,VWXQFHJBQHTHMK-LURJTMIESA-N,,,,
78,AJPADPZSRRUGHI-RFZPGFLSSA-N,,,,
79,LKDRXBCSQODPBY-BGPJRJDNSA-N,,,,
80,QNAYBMKLOCPYGJ-UWTATZPHSA-N,,,,
81,JVTAAEKCZFNVCJ-UWTATZPHSA-N,,leigh syndrome,biolink:Pathway,SMP00196
81,JVTAAEKCZFNVCJ-UWTATZPHSA-N,,"primary hyperoxaluria ii, ph2",biolink:Pathway,SMP00558
81,JVTAAEKCZFNVCJ-UWTATZPHSA-N,,pyruvaldehyde degradation,biolink:Pathway,SMP00459
81,JVTAAEKCZFNVCJ-UWTATZPHSA-N,,pyruvate decarboxylase e1 component deficiency (pdhe1 deficiency),biolink:Pathway,SMP00334
81,JVTAAEKCZFNVCJ-UWTATZPHSA-N,,pyruvate dehydrogenase complex deficiency,biolink:Pathway,SMP00212
81,JVTAAEKCZFNVCJ-UWTATZPHSA-N,,pyruvate kinase deficiency,biolink:Pathway,SMP00559
81,JVTAAEKCZFNVCJ-UWTATZPHSA-N,map00620,pyruvate metabolism,biolink:Pathway,
82,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,,alkaptonuria,biolink:Pathway,SMP00169
82,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,,disulfiram action pathway,biolink:Pathway,SMP00429
82,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,,dopamine beta-hydroxylase deficiency,biolink:Pathway,SMP00498
82,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,,hawkinsinuria,biolink:Pathway,SMP00190
82,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,,monoamine oxidase-a deficiency (mao-a),biolink:Pathway,SMP00533
82,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
82,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,,tyrosinemia type i,biolink:Pathway,SMP00218
82,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,,"tyrosinemia, transient, of the newborn",biolink:Pathway,SMP00494
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,acute intermittent porphyria,biolink:Pathway,SMP00344
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,carnitine synthesis,biolink:Pathway,SMP00465
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,clomipramine metabolism pathway,biolink:Pathway,SMP00639
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,congenital erythropoietic porphyria (cep) or gunther disease,biolink:Pathway,SMP00345
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,degradation of superoxides,biolink:Pathway,SMP00468
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,ethanol degradation,biolink:Pathway,SMP00449
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,hereditary coproporphyria (hcp),biolink:Pathway,SMP00342
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,homocysteine degradation,biolink:Pathway,SMP00455
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,leigh syndrome,biolink:Pathway,SMP00196
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,malonic aciduria,biolink:Pathway,SMP00198
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,malonyl-coa decarboxylase deficiency,biolink:Pathway,SMP00502
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,methylmalonic aciduria due to cobalamin-related disorders,biolink:Pathway,SMP00201
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,mitochondrial beta-oxidation of long chain saturated fatty acids,biolink:Pathway,SMP00482
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,mitochondrial beta-oxidation of medium chain saturated fatty acids,biolink:Pathway,SMP00481
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,mitochondrial beta-oxidation of short chain saturated fatty acids,biolink:Pathway,SMP00480
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,omeprazole action pathway,biolink:Pathway,SMP00226
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,omeprazole metabolism pathway,biolink:Pathway,SMP00613
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,map00190,oxidative phosphorylation,biolink:Pathway,
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,pantoprazole action pathway,biolink:Pathway,SMP00228
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,pantoprazole metabolism pathway,biolink:Pathway,SMP00615
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,plasmalogen synthesis,biolink:Pathway,SMP00479
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,porphyria variegata (pv),biolink:Pathway,SMP00346
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,map00860,porphyrin metabolism,biolink:Pathway,SMP00024
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,"primary hyperoxaluria ii, ph2",biolink:Pathway,SMP00558
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,map00640,propanoate metabolism,biolink:Pathway,
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,pyruvaldehyde degradation,biolink:Pathway,SMP00459
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,pyruvate decarboxylase e1 component deficiency (pdhe1 deficiency),biolink:Pathway,SMP00334
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,pyruvate dehydrogenase complex deficiency,biolink:Pathway,SMP00212
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,pyruvate kinase deficiency,biolink:Pathway,SMP00559
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,map00620,pyruvate metabolism,biolink:Pathway,
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,rabeprazole action pathway,biolink:Pathway,SMP00229
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,rabeprazole metabolism pathway,biolink:Pathway,SMP00616
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,threonine and 2-oxobutanoate degradation,biolink:Pathway,SMP00452
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,transfer of acetyl groups into mitochondria,biolink:Pathway,SMP00466
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,trehalose degradation,biolink:Pathway,SMP00467
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,map00350,tyrosine metabolism,biolink:Pathway,
83,UFHFLCQGNIYNRP-UHFFFAOYSA-N,,warburg effect,biolink:Pathway,SMP00654
84,GMKMEZVLHJARHF-WHFBIAKZSA-N,,,,
85,OVPRPPOVAXRCED-WVZVXSGGSA-N,,,,
86,ALYNCZNDIQEVRV-UHFFFAOYSA-N,,,,
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,,cystathionine beta-synthase deficiency,biolink:Pathway,SMP00177
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,,glycine n-methyltransferase deficiency,biolink:Pathway,SMP00222
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,,"homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblg complementation type",biolink:Pathway,SMP00570
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,,hypermethioninemia,biolink:Pathway,SMP00341
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,,methionine adenosyltransferase deficiency,biolink:Pathway,SMP00221
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,map00270,methionine metabolism,biolink:Pathway,SMP00033
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,,methylenetetrahydrofolate reductase deficiency (mthfrd),biolink:Pathway,SMP00340
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,,s-adenosylhomocysteine (sah) hydrolase deficiency,biolink:Pathway,SMP00214
87,KIDHWZJUCRJVML-UHFFFAOYSA-N,,spermidine and spermine biosynthesis,biolink:Pathway,SMP00445
88,GACTWZZMVMUKNG-KVTDHHQDSA-N,,,,
89,CSCPPACGZOOCGX-UHFFFAOYSA-N,map00072,ketone body metabolism,biolink:Pathway,SMP00071
89,CSCPPACGZOOCGX-UHFFFAOYSA-N,,succinyl coa: 3-ketoacid coa transferase deficiency,biolink:Pathway,SMP00569
90,YQUVCSBJEUQKSH-UHFFFAOYSA-N,,,,
91,IWDCLRJOBJJRNH-UHFFFAOYSA-N,,,,
92,WPYMKLBDIGXBTP-UHFFFAOYSA-N,,,,
93,QAIPRVGONGVQAS-DUXPYHPUSA-N,,,,
94,HCFRWBBJISAZNK-UHFFFAOYSA-N,,,,
95,RLSSMJSEOOYNOY-UHFFFAOYSA-N,,,,
96,QWVGKYWNOKOFNN-UHFFFAOYSA-N,,,,
97,KLZGKIDSEJWEDW-UHFFFAOYSA-N,,,,
98,JMSVCTWVEWCHDZ-UHFFFAOYSA-N,,,,
99,LVHBHZANLOWSRM-UHFFFAOYSA-N,,,,
100,JTEDVYBZBROSJT-UHFFFAOYSA-N,,,,
101,NMHMNPHRMNGLLB-UHFFFAOYSA-N,,,,
102,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,,,,
103,VEVJTUNLALKRNO-TYHXJLICSA-N,,,,
104,GOLXRNDWAUTYKT-UHFFFAOYSA-N,,,,
105,QMMFVYPAHWMCMS-UHFFFAOYSA-N,,,,
106,VHRGRCVQAFMJIZ-UHFFFAOYSA-N,,,,
107,TXXHDPDFNKHHGW-ZPUQHVIOSA-N,,,,
108,IJFXRHURBJZNAO-UHFFFAOYSA-N,,,,
109,KHTAGVZHYUZYMF-UHFFFAOYSA-N,,,,
110,BLHCMGRVFXRYRN-UHFFFAOYSA-N,,,,
111,VNWKTOKETHGBQD-UHFFFAOYSA-N,,,,
112,JKQXZKUSFCKOGQ-QAYBQHTQSA-N,,,,
113,OWBTYPJTUOEWEK-UHFFFAOYSA-N,,,,
114,RWSOTUBLDIXVET-UHFFFAOYSA-N,,beta-mercaptolactate-cysteine disulfiduria,biolink:Pathway,SMP00499
114,RWSOTUBLDIXVET-UHFFFAOYSA-N,map00270,cysteine metabolism,biolink:Pathway,SMP00013
114,RWSOTUBLDIXVET-UHFFFAOYSA-N,,"cystinosis, ocular nonnephropathic",biolink:Pathway,SMP00722
115,VGEREEWJJVICBM-UHFFFAOYSA-N,,,,
116,WHUUTDBJXJRKMK-GSVOUGTGSA-N,,,,
117,JJMDCOVWQOJGCB-UHFFFAOYSA-N,,,,
118,MBBOMCVGYCRMEA-UHFFFAOYSA-N,,,,
119,RAJWOBJTTGJROA-QJISAEMRSA-N,,androstenedione metabolism,biolink:Pathway,SMP30406
120,SXDXRJZUAJBNFL-XKSSXDPKSA-N,map00740,riboflavin metabolism,biolink:Pathway,SMP00070
121,RQRINYISXYAZKL-RPDRRWSUSA-N,,,,
122,BEOUGZFCUMNGOU-UHFFFAOYSA-N,,,,
123,PTHCMJGKKRQCBF-ICIGWGHZSA-N,map00052,galactose metabolism,biolink:Pathway,SMP00043
124,YCCILVSKPBXVIP-UHFFFAOYSA-N,,,,
125,LRHPLDYGYMQRHN-UHFFFAOYSA-N,,,,
126,CHTHALBTIRVDBM-UHFFFAOYSA-N,,,,
127,HHVIBTZHLRERCL-UHFFFAOYSA-N,,,,
128,JUUBCHWRXWPFFH-UHFFFAOYSA-N,,,,
129,ZXEKIIBDNHEJCQ-UHFFFAOYSA-N,,,,
130,PHTQWCKDNZKARW-UHFFFAOYSA-N,,,,
131,XDOFWFNMYJRHEW-UHFFFAOYSA-N,,,,
132,TXXHDPDFNKHHGW-CCAGOZQPSA-N,,,,
133,JFLIEFSWGNOPJJ-JTQLQIEISA-N,map00360,phenylalanine metabolism,biolink:Pathway,
134,ZOSQFDVXNQFKBY-CGAXJHMRSA-N,,,,
135,NUZLRKBHOBPTQV-ARJAWSKDSA-N,,,,
136,WFPZSXYXPSUOPY-ROYWQJLOSA-N,,,,
137,ZKLLSNQJRLJIGT-OTWZMJIISA-N,,,,
138,CJJCPDZKQKUXSS-ARQDHWQXSA-N,,,,
139,WGNAKZGUSRVWRH-UHFFFAOYSA-N,,,,
140,IZSRJDGCGRAUAR-UHFFFAOYSA-N,,,,
141,YPGCWEMNNLXISK-UHFFFAOYSA-N,,,,
142,BHHGXPLMPWCGHP-UHFFFAOYSA-N,,,,
143,WQZGKKKJIJFFOK-QRXFDPRISA-N,,,,
144,GZQKNULLWNGMCW-PWQABINMSA-N,,,,
145,BFVQTKQTUCQRPI-YYEZTRBPSA-N,,,,
146,AAXCQFOXUJMCCW-PETQGJDISA-N,,,,
147,QCDYQQDYXPDABM-UHFFFAOYSA-N,,,,
148,ZNXXWTPQHVLMQT-MRVPVSSYSA-N,,,,
149,OLNJUISKUQQNIM-UHFFFAOYSA-N,,,,
150,KTHADMDGDNYQRX-UHFFFAOYSA-N,,,,
151,SRBFZHDQGSBBOR-SQOUGZDYSA-N,,,,
152,KQTIIICEAUMSDG-UHFFFAOYSA-N,,,,
153,RWRDLPDLKQPQOW-UHFFFAOYSA-N,,,,
154,RSTKLPZEZYGQPY-UHFFFAOYSA-N,,,,
155,XVARCVCWNFACQC-RKQHYHRCSA-N,,,,
156,TXXHDPDFNKHHGW-UHFFFAOYSA-N,,,,
